A	O
new	O
marker	B:C0005516
for	O
breast	O
cancer	O
diagnosis	O
,	O
human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
:	O
A	O
preliminary	O
study	O
.	O

A	O
new	O
marker	O
for	O
breast	O
cancer	O
diagnosis	O
,	O
human	B:C2707001
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
:	O
A	O
preliminary	O
study	O
.	O

A	O
new	O
marker	O
for	O
breast	O
cancer	O
diagnosis	O
,	O
human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
:	O
A	O
preliminary	O
study	B:C2603343
.	O

Breast	B:C0678222
cancer	I:C0678222
is	O
the	O
most	O
frequently	O
diagnosed	O
cancer	O
type	O
in	O
women	O
.	O

Breast	O
cancer	I:C0678222
is	O
the	O
most	O
frequently	O
diagnosed	B:C0011900
cancer	O
type	O
in	O
women	O
.	O

Breast	O
cancer	I:C0678222
is	O
the	O
most	O
frequently	O
diagnosed	O
cancer	B:C0006826
type	O
in	O
women	O
.	O

Breast	O
cancer	I:C0678222
is	O
the	O
most	O
frequently	O
diagnosed	O
cancer	O
type	O
in	O
women	B:C0043210
.	O

Tumor	B:C0041365
markers	I:C0041365
have	O
been	O
widely	O
used	O
for	O
assessing	O
the	O
treatment	O
response	I:C0521982
and	O
early	O
diagnosis	I:C0596473
of	O
recurrence	O
.	O

Tumor	O
markers	I:C0041365
have	O
been	O
widely	O
used	O
for	O
assessing	O
the	O
treatment	B:C0521982
response	I:C0521982
and	O
early	O
diagnosis	I:C0596473
of	O
recurrence	O
.	O

Tumor	O
markers	I:C0041365
have	O
been	O
widely	O
used	O
for	O
assessing	O
the	O
treatment	O
response	I:C0521982
and	O
early	B:C0596473
diagnosis	I:C0596473
of	O
recurrence	O
.	O

Human	B:C2707001
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
(	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
)	O
is	O
expressed	O
in	O
ductal	O
carcinoma	I:C1527349
of	I:C1527349
the	I:C1527349
breast	I:C1527349
tissue	I:C1527349
;	O
however	O
,	O
its	O
serum	O
levels	O
and	O
their	O
diagnostic	O
and	O
prognostic	O
potential	O
in	O
breast	O
cancer	I:C0678222
have	O
not	O
been	O
investigated	O
,	O
which	O
was	O
therefore	O
the	O
aim	O
of	O
the	O
present	O
study	O
.	O

Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
(	O
Human	B:C2707001
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
)	O
is	O
expressed	O
in	O
ductal	O
carcinoma	I:C1527349
of	I:C1527349
the	I:C1527349
breast	I:C1527349
tissue	I:C1527349
;	O
however	O
,	O
its	O
serum	O
levels	O
and	O
their	O
diagnostic	O
and	O
prognostic	O
potential	O
in	O
breast	O
cancer	I:C0678222
have	O
not	O
been	O
investigated	O
,	O
which	O
was	O
therefore	O
the	O
aim	O
of	O
the	O
present	O
study	O
.	O

Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
(	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
)	O
is	O
expressed	B:C1171362
in	O
ductal	O
carcinoma	I:C1527349
of	I:C1527349
the	I:C1527349
breast	I:C1527349
tissue	I:C1527349
;	O
however	O
,	O
its	O
serum	O
levels	O
and	O
their	O
diagnostic	O
and	O
prognostic	O
potential	O
in	O
breast	O
cancer	I:C0678222
have	O
not	O
been	O
investigated	O
,	O
which	O
was	O
therefore	O
the	O
aim	O
of	O
the	O
present	O
study	O
.	O

Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
(	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
)	O
is	O
expressed	O
in	O
ductal	B:C1527349
carcinoma	I:C1527349
of	I:C1527349
the	I:C1527349
breast	I:C1527349
tissue	I:C1527349
;	O
however	O
,	O
its	O
serum	O
levels	O
and	O
their	O
diagnostic	O
and	O
prognostic	O
potential	O
in	O
breast	O
cancer	I:C0678222
have	O
not	O
been	O
investigated	O
,	O
which	O
was	O
therefore	O
the	O
aim	O
of	O
the	O
present	O
study	O
.	O

Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
(	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
)	O
is	O
expressed	O
in	O
ductal	O
carcinoma	I:C1527349
of	I:C1527349
the	I:C1527349
breast	I:C1527349
tissue	I:C1527349
;	O
however	O
,	O
its	O
serum	B:C0229671
levels	O
and	O
their	O
diagnostic	O
and	O
prognostic	O
potential	O
in	O
breast	O
cancer	I:C0678222
have	O
not	O
been	O
investigated	O
,	O
which	O
was	O
therefore	O
the	O
aim	O
of	O
the	O
present	O
study	O
.	O

Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
(	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
)	O
is	O
expressed	O
in	O
ductal	O
carcinoma	I:C1527349
of	I:C1527349
the	I:C1527349
breast	I:C1527349
tissue	I:C1527349
;	O
however	O
,	O
its	O
serum	O
levels	O
and	O
their	O
diagnostic	B:C0011900
and	O
prognostic	O
potential	O
in	O
breast	O
cancer	I:C0678222
have	O
not	O
been	O
investigated	O
,	O
which	O
was	O
therefore	O
the	O
aim	O
of	O
the	O
present	O
study	O
.	O

Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
(	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
)	O
is	O
expressed	O
in	O
ductal	O
carcinoma	I:C1527349
of	I:C1527349
the	I:C1527349
breast	I:C1527349
tissue	I:C1527349
;	O
however	O
,	O
its	O
serum	O
levels	O
and	O
their	O
diagnostic	O
and	O
prognostic	B:C0420834
potential	O
in	O
breast	O
cancer	I:C0678222
have	O
not	O
been	O
investigated	O
,	O
which	O
was	O
therefore	O
the	O
aim	O
of	O
the	O
present	O
study	O
.	O

Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
(	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
)	O
is	O
expressed	O
in	O
ductal	O
carcinoma	I:C1527349
of	I:C1527349
the	I:C1527349
breast	I:C1527349
tissue	I:C1527349
;	O
however	O
,	O
its	O
serum	O
levels	O
and	O
their	O
diagnostic	O
and	O
prognostic	O
potential	O
in	O
breast	B:C0678222
cancer	I:C0678222
have	O
not	O
been	O
investigated	O
,	O
which	O
was	O
therefore	O
the	O
aim	O
of	O
the	O
present	O
study	O
.	O

Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
(	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
)	O
is	O
expressed	O
in	O
ductal	O
carcinoma	I:C1527349
of	I:C1527349
the	I:C1527349
breast	I:C1527349
tissue	I:C1527349
;	O
however	O
,	O
its	O
serum	O
levels	O
and	O
their	O
diagnostic	O
and	O
prognostic	O
potential	O
in	O
breast	O
cancer	I:C0678222
have	O
not	O
been	O
investigated	O
,	O
which	O
was	O
therefore	O
the	O
aim	O
of	O
the	O
present	O
study	B:C2603343
.	O

The	O
serum	B:C0229671
levels	O
of	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
were	O
determined	O
in	O
36	O
breast	O
cancer	I:C0678222
patients	O
,	O
11	O
ovarian	O
cancer	I:C0029925
patients	O
and	O
16	O
healthy	O
volunteers	I:C1708335
.	O

The	O
serum	O
levels	O
of	O
Human	B:C2707001
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
were	O
determined	O
in	O
36	O
breast	O
cancer	I:C0678222
patients	O
,	O
11	O
ovarian	O
cancer	I:C0029925
patients	O
and	O
16	O
healthy	O
volunteers	I:C1708335
.	O

The	O
serum	O
levels	O
of	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
were	O
determined	B:C1148554
in	O
36	O
breast	O
cancer	I:C0678222
patients	O
,	O
11	O
ovarian	O
cancer	I:C0029925
patients	O
and	O
16	O
healthy	O
volunteers	I:C1708335
.	O

The	O
serum	O
levels	O
of	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
were	O
determined	O
in	O
36	O
breast	B:C0678222
cancer	I:C0678222
patients	O
,	O
11	O
ovarian	O
cancer	I:C0029925
patients	O
and	O
16	O
healthy	O
volunteers	I:C1708335
.	O

The	O
serum	O
levels	O
of	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
were	O
determined	O
in	O
36	O
breast	O
cancer	I:C0678222
patients	O
,	O
11	O
ovarian	B:C0029925
cancer	I:C0029925
patients	O
and	O
16	O
healthy	O
volunteers	I:C1708335
.	O

The	O
serum	O
levels	O
of	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
were	O
determined	O
in	O
36	O
breast	O
cancer	I:C0678222
patients	O
,	O
11	O
ovarian	O
cancer	I:C0029925
patients	O
and	O
16	O
healthy	B:C1708335
volunteers	I:C1708335
.	O

The	O
association	O
between	O
clinicopathological	O
characteristics	O
of	O
breast	B:C0678222
cancer	I:C0678222
and	O
serum	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
levels	O
was	O
investigated	O
.	O

The	O
association	O
between	O
clinicopathological	O
characteristics	O
of	O
breast	O
cancer	I:C0678222
and	O
serum	B:C0229671
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
levels	O
was	O
investigated	O
.	O

The	O
association	O
between	O
clinicopathological	O
characteristics	O
of	O
breast	O
cancer	I:C0678222
and	O
serum	O
Human	B:C2707001
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
levels	O
was	O
investigated	O
.	O

A	O
significant	O
difference	O
in	O
the	O
median	O
serum	B:C0229671
levels	O
of	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
was	O
identified	O
between	O
breast	O
cancer	I:C0678222
patients	O
,	O
ovarian	O
cancer	I:C0029925
patients	O
and	O
healthy	O
volunteers	I:C1708335
(	O
P=0.013	O
)	O
.	O

A	O
significant	O
difference	O
in	O
the	O
median	O
serum	O
levels	O
of	O
Human	B:C2707001
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
was	O
identified	O
between	O
breast	O
cancer	I:C0678222
patients	O
,	O
ovarian	O
cancer	I:C0029925
patients	O
and	O
healthy	O
volunteers	I:C1708335
(	O
P=0.013	O
)	O
.	O

A	O
significant	O
difference	O
in	O
the	O
median	O
serum	O
levels	O
of	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
was	O
identified	O
between	O
breast	B:C0678222
cancer	I:C0678222
patients	O
,	O
ovarian	O
cancer	I:C0029925
patients	O
and	O
healthy	O
volunteers	I:C1708335
(	O
P=0.013	O
)	O
.	O

A	O
significant	O
difference	O
in	O
the	O
median	O
serum	O
levels	O
of	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
was	O
identified	O
between	O
breast	O
cancer	I:C0678222
patients	O
,	O
ovarian	B:C0029925
cancer	I:C0029925
patients	O
and	O
healthy	O
volunteers	I:C1708335
(	O
P=0.013	O
)	O
.	O

A	O
significant	O
difference	O
in	O
the	O
median	O
serum	O
levels	O
of	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
was	O
identified	O
between	O
breast	O
cancer	I:C0678222
patients	O
,	O
ovarian	O
cancer	I:C0029925
patients	O
and	O
healthy	B:C1708335
volunteers	I:C1708335
(	O
P=0.013	O
)	O
.	O

The	O
cutoff	O
value	O
for	O
the	O
prediction	O
of	O
breast	B:C0678222
cancer	I:C0678222
was	O
determined	O
at	O
>	O
13.24	O
pmol	O
/	O
l	O
for	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
,	O
with	O
a	O
sensitivity	O
of	O
61.11	O
%	O
,	O
specificity	O
of	O
68.75	O
%	O
,	O
positive	O
predictive	O
value	O
of	O
81.48	O
%	O
,	O
negative	O
predictive	O
value	O
of	O
44.0	O
%	O
and	O
accuracy	O
of	O
63.46	O
%	O
.	O

The	O
cutoff	O
value	O
for	O
the	O
prediction	O
of	O
breast	O
cancer	I:C0678222
was	O
determined	B:C1148554
at	O
>	O
13.24	O
pmol	O
/	O
l	O
for	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
,	O
with	O
a	O
sensitivity	O
of	O
61.11	O
%	O
,	O
specificity	O
of	O
68.75	O
%	O
,	O
positive	O
predictive	O
value	O
of	O
81.48	O
%	O
,	O
negative	O
predictive	O
value	O
of	O
44.0	O
%	O
and	O
accuracy	O
of	O
63.46	O
%	O
.	O

The	O
cutoff	O
value	O
for	O
the	O
prediction	O
of	O
breast	O
cancer	I:C0678222
was	O
determined	O
at	O
>	O
13.24	O
pmol	O
/	O
l	O
for	O
Human	B:C2707001
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
,	O
with	O
a	O
sensitivity	O
of	O
61.11	O
%	O
,	O
specificity	O
of	O
68.75	O
%	O
,	O
positive	O
predictive	O
value	O
of	O
81.48	O
%	O
,	O
negative	O
predictive	O
value	O
of	O
44.0	O
%	O
and	O
accuracy	O
of	O
63.46	O
%	O
.	O

Furthermore	O
,	O
a	O
positive	B:C1446409
correlation	O
between	O
the	O
serum	O
levels	O
of	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
and	O
cancer	O
antigen	I:C0003341
15	O
-	O
3	O
was	O
determined	O
(	O
r=0.399	O
,	O
P=0.026	O
)	O
.	O

Furthermore	O
,	O
a	O
positive	O
correlation	O
between	O
the	O
serum	B:C0229671
levels	O
of	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
and	O
cancer	O
antigen	I:C0003341
15	O
-	O
3	O
was	O
determined	O
(	O
r=0.399	O
,	O
P=0.026	O
)	O
.	O

Furthermore	O
,	O
a	O
positive	O
correlation	O
between	O
the	O
serum	O
levels	O
of	O
Human	B:C2707001
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
and	O
cancer	O
antigen	I:C0003341
15	O
-	O
3	O
was	O
determined	O
(	O
r=0.399	O
,	O
P=0.026	O
)	O
.	O

Furthermore	O
,	O
a	O
positive	O
correlation	O
between	O
the	O
serum	O
levels	O
of	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
and	O
cancer	B:C0003341
antigen	I:C0003341
15	O
-	O
3	O
was	O
determined	O
(	O
r=0.399	O
,	O
P=0.026	O
)	O
.	O

Furthermore	O
,	O
a	O
positive	O
correlation	O
between	O
the	O
serum	O
levels	O
of	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
and	O
cancer	O
antigen	I:C0003341
15	O
-	O
3	O
was	O
determined	B:C1148554
(	O
r=0.399	O
,	O
P=0.026	O
)	O
.	O

To	O
the	O
best	O
of	O
our	O
knowledge	B:C0376554
,	O
the	O
present	O
study	O
was	O
the	O
first	O
to	O
determine	O
the	O
diagnostic	O
value	O
of	O
serum	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
for	O
breast	O
cancer	I:C0678222
.	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
the	O
present	O
study	B:C2603343
was	O
the	O
first	O
to	O
determine	O
the	O
diagnostic	O
value	O
of	O
serum	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
for	O
breast	O
cancer	I:C0678222
.	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
the	O
present	O
study	O
was	O
the	O
first	O
to	O
determine	B:C1148554
the	O
diagnostic	O
value	O
of	O
serum	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
for	O
breast	O
cancer	I:C0678222
.	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
the	O
present	O
study	O
was	O
the	O
first	O
to	O
determine	O
the	O
diagnostic	O
value	O
of	O
serum	B:C0229671
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
for	O
breast	O
cancer	I:C0678222
.	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
the	O
present	O
study	O
was	O
the	O
first	O
to	O
determine	O
the	O
diagnostic	O
value	O
of	O
serum	O
Human	B:C2707001
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
for	O
breast	O
cancer	I:C0678222
.	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
the	O
present	O
study	O
was	O
the	O
first	O
to	O
determine	O
the	O
diagnostic	O
value	O
of	O
serum	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
for	O
breast	B:C0678222
cancer	I:C0678222
.	O

A	O
significant	O
elevation	B:C0702240
of	O
serum	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
levels	O
in	O
patients	O
with	O
breast	O
cancer	I:C0678222
compared	O
with	O
that	O
in	O
healthy	O
controls	O
was	O
identified	O
.	O

A	O
significant	O
elevation	O
of	O
serum	B:C0229671
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
levels	O
in	O
patients	O
with	O
breast	O
cancer	I:C0678222
compared	O
with	O
that	O
in	O
healthy	O
controls	O
was	O
identified	O
.	O

A	O
significant	O
elevation	O
of	O
serum	O
Human	B:C2707001
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
levels	O
in	O
patients	O
with	O
breast	O
cancer	I:C0678222
compared	O
with	O
that	O
in	O
healthy	O
controls	O
was	O
identified	O
.	O

A	O
significant	O
elevation	O
of	O
serum	O
Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
levels	O
in	O
patients	O
with	O
breast	B:C0678222
cancer	I:C0678222
compared	O
with	O
that	O
in	O
healthy	O
controls	O
was	O
identified	O
.	O

Human	B:C2707001
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
may	O
serve	O
as	O
a	O
novel	O
biomarker	O
for	O
the	O
diagnosis	O
of	O
breast	O
cancer	I:C0678222
.	O

Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
may	O
serve	O
as	O
a	O
novel	O
biomarker	B:C0005516
for	O
the	O
diagnosis	O
of	O
breast	O
cancer	I:C0678222
.	O

Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
may	O
serve	O
as	O
a	O
novel	O
biomarker	O
for	O
the	O
diagnosis	B:C0011900
of	O
breast	O
cancer	I:C0678222
.	O

Human	O
epididymis	I:C2707001
protein	I:C2707001
4	I:C2707001
may	O
serve	O
as	O
a	O
novel	O
biomarker	O
for	O
the	O
diagnosis	O
of	O
breast	B:C0678222
cancer	I:C0678222
.	O

